AACC/NKF Guidance Document on Improving Equity in Chronic Kidney Disease Care.
Christina C PierreMark A MarzinkeSofia B AhmedDavid CollisterJessica M Colón-FrancoMelanie P HoenigThomas S LoreyPaul M PalevskyOctavia M Peck PalmerSylvia E RosasJoseph VassalottiCameron T WhitleyDina N GreenePublished in: The journal of applied laboratory medicine (2023)
Implementation of the CKD-EPI 2021 eGFR equations represents progress toward health equity in the management of KD. Ongoing efforts by multidisciplinary teams, including clinical laboratorians, should focus on improved disease detection in clinically and socially high-risk populations. Routine use of cystatin C is recommended to improve the accuracy of eGFR, particularly in patients whose blood creatinine concentrations are confounded by processes other than glomerular filtration. When managing gender-diverse individuals, eGFR should be calculated and reported with both male and female coefficients. Gender-diverse individuals can benefit from a more holistic management approach, particularly at important clinical decision points.
Keyphrases
- small cell lung cancer
- epidermal growth factor receptor
- healthcare
- quality improvement
- tyrosine kinase
- end stage renal disease
- chronic kidney disease
- mental health
- newly diagnosed
- primary care
- public health
- ejection fraction
- palliative care
- prognostic factors
- clinical practice
- peritoneal dialysis
- risk assessment
- pain management
- health information
- label free
- social media
- climate change
- human health
- patient reported
- real time pcr
- high glucose